Focus Partners Wealth
HRMY icon

Focus Partners Wealth’s Harmony Biosciences HRMY Stock Holding History

Focus Partners Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
+6,848
New +$216K ﹤0.01% 2368
2026
Q1 		– Sell
-6,595
Closed -$247K – 2737
2025
Q4 		$247K Buy
+6,595
New +$217K ﹤0.01% 2335

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Wealth's HRMY Position: Q2 2026 in Review

Focus Partners Wealth opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 6,848 shares worth $249K. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in HRMY as recently as Q4 2025.

Focus Partners Wealth first reported a position in HRMY in Q4 2025 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Focus Partners Wealth held 6,848 shares of Harmony Biosciences worth $249K as of Q2 2026.
  • Harmony Biosciences was a new Focus Partners Wealth position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2368 holding.
  • Focus Partners Wealth first reported a position in Harmony Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.